Next Article in Journal
Dye Sensitization for Ultraviolet Upconversion Enhancement
Previous Article in Journal
Structural and Optical Properties of Silicon Carbide Powders Synthesized from Organosilane Using High-Temperature High-Pressure Method
Previous Article in Special Issue
Zinc Oxide Nanoparticles Induce an Adverse Effect on Blood Glucose Levels Depending On the Dose and Route of Administration in Healthy and Diabetic Rats
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Toxicology and Biocompatibility of Nanomaterials

Institute of Biological and Chemical Systems-Biological Information Processing, Karlsruhe Institute of Technology (KIT), Hermann-von-Helmholtz-Platz 1, 76344 Eggenstein-Leopoldshafen, Germany
*
Author to whom correspondence should be addressed.
Nanomaterials 2021, 11(11), 3110; https://doi.org/10.3390/nano11113110
Submission received: 11 November 2021 / Accepted: 17 November 2021 / Published: 18 November 2021
(This article belongs to the Special Issue Toxicology and Biocompatibility of Nanomaterials)
It is our great pleasure to introduce this Special Issue entitled “Toxicology and Biocompatibility of Nanomaterials”. As the understanding of materials at the nanoscale and the ability to control their structure improves, a wide range of nanomaterials (NMs) with novel characteristics and applications are being fabricated for electronics, engineering, and, more recently, biomedical research applications. Although the technological and economic benefits of NMs are obvious, concern has also been raised that the very same properties, which enable a variety of novel applications, might have adverse effects if such a material is inhaled, ingested, applied to the skin or even released into the environment [1]. These concerns have led to an increasing discussion worldwide about possible regulatory policies for NMs. Therefore, there is a clear need to establish convincing scientific knowledge to assess the impact of NMs on human health and the ecosystem. These questions can only be tackled by collaborative research at the interface of engineering, physics, chemistry, toxicology and biology, as outlined in our first Special Issue on the topic one decade ago [2]. Meanwhile, the field of nanotoxicology has come of age, and is an established discipline in toxicology.
This Special Issue comprises six research articles and two timely reviews and covers research in the field of nanotoxicology, with a particular interest in molecular mechanism of action as well as the safe-by-design concept, i.e., the synthesis of biocompatible nanomaterials. Additionally, the impact of the biomolecular corona, which is the interaction of biomolecules with the NM surface, on toxicity and biocompatibility, is addressed.
The first study addresses the effects of ZnO NMs on blood glucose levels in healthy and diabetic rats and discusses potential clinical applications [3]. The following articles are mainly in vitro studies with a focus on mechanisms of NM toxicity. Macrophages are important targets of NMs; therefore, the understanding of molecular initiating events is of high relevance. A series of TiO2 NMs with different characteristics were studied in rat alveolar macrophages and activation of the NLRP3 inflammasome is presented, highlighting the importance of case-to-case studies for proper hazard assessment [4]. In murine macrophages, the poorly understood mixture effects of co-pollutants and NMs has been investigated [5]. The authors demonstrate synergistic activities of silica NMs and genotoxic agents, thus reinforcing the notion that there is an urgent need to pay more attention to mixture effects in the future. Apart from the innate immune system, the gastrointestinal tract is an important target tissue. Therefore, the toxicity of silica NMs is explored in gastrointestinal cells [6], specifically in the presence or absence of serum, because the biomolecular corona has previously been shown to critically determine detrimental effects in other cell types [7]. Although in the presence of serum even pro-proliferative effects have been shown in gastric cells [8], in the absence of serum, silica NMs potently induce cell death in colon carcinoma cells; however, this is independent of the key regulators p53 and BAX, suggesting the potential for their further development as anticancer nanodrugs [6]. Although the field of nanotoxicology has matured and solved most of the initial technical problems and challenges, there are still issues which hamper proper hazard assessment. These include, but are not limited to, the reproducible synthesis of NMs with clearly characterized physico-chemical properties [9], as well as the establishment of more physiologically relevant test systems [10] and standard operating procedures for toxicity testing to provide comparable results across laboratories. Thus, fifteen European laboratories performed an inter-laboratory comparison to assess the toxicity of polystyrene NMs with the widely used MTS assay and provide guidance on how to improve reliable testing [11]. Finally, the interactions of CeO2 and TiO2 NMs and algae were addressed in an ecotoxicity study, and the importance of the adherence of NMs to the test organism was identified as an important parameter to predict toxicity [12].
Two reviews conclude this Special Issue. The first summarizes our knowledge of airborne NMs and their potential adverse effects on the nervous system with a specific focus on neurodegenerative diseases [13]. The final contribution provides a fresh outlook on positive aspects of NM actions in biological systems, i.e., their use in medicine as tools to diagnose and treat cancer [14].
In conclusion, we would like to thank all the authors for their interesting and excellent contributions, and the many constructive reviewers and the editorial team who helped to bring this Special Issue to fruition. We hope that a broad readership will enjoy this Special Issue.

Author Contributions

C.W. prepared the original draft, which was reviewed and edited by S.D. All authors have read and agreed to the published version of the manuscript.

Funding

This article received no external funding.

Data Availability Statement

Not applicable.

Acknowledgments

We are grateful to Mirabelle Wang from Nanomaterials for her continuous support. We are grateful to all the authors for submitting their studies to the present Special Issue and for its successful completion. We deeply acknowledge the Nanomaterials reviewers for enhancing the quality and impact of all submitted papers.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Gebel, T.; Foth, H.; Damm, G.; Freyberger, A.; Kramer, P.J.; Lilienblum, W.; Rohl, C.; Schupp, T.; Weiss, C.; Wollin, K.M.; et al. Manufactured nanomaterials: Categorization and approaches to hazard assessment. Arch. Toxicol. 2014, 88, 2191–2211. [Google Scholar] [CrossRef] [PubMed]
  2. Weiss, C.; Diabate, S. A special issue on nanotoxicology. Arch. Toxicol. 2011, 85, 705–706. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Virgen-Ortiz, A.; Apolinar-Iribe, A.; Diaz-Reval, I.; Parra-Delgado, H.; Limon-Miranda, S.; Sanchez-Pastor, E.A.; Castro-Sanchez, L.; Jesus Castillo, S.; Dagnino-Acosta, A.; Bonales-Alatorre, E.; et al. Zinc Oxide Nanoparticles Induce an Adverse Effect on Blood Glucose Levels Depending on the Dose and Route of Administration in Healthy and Diabetic Rats. Nanomaterials 2020, 10, 2005. [Google Scholar] [CrossRef] [PubMed]
  4. Kolling, J.; Tigges, J.; Hellack, B.; Albrecht, C.; Schins, R.P.F. Evaluation of the NLRP3 Inflammasome Activating Effects of a Large Panel of TiO2 Nanomaterials in Macrophages. Nanomaterials 2020, 10, 1876. [Google Scholar] [CrossRef] [PubMed]
  5. Dussert, F.; Arthaud, P.A.; Arnal, M.E.; Dalzon, B.; Torres, A.; Douki, T.; Herlin, N.; Rabilloud, T.; Carriere, M. Toxicity to RAW264.7 Macrophages of Silica Nanoparticles and the E551 Food Additive, in Combination with Genotoxic Agents. Nanomaterials 2020, 10, 1418. [Google Scholar] [CrossRef] [PubMed]
  6. Fritsch-Decker, S.; An, Z.; Yan, J.; Hansjosten, I.; Al-Rawi, M.; Peravali, R.; Diabate, S.; Weiss, C. Silica Nanoparticles Provoke Cell Death Independent of p53 and BAX in Human Colon Cancer Cells. Nanomaterials 2019, 9, 1172. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  7. Leibe, R.; Hsiao, I.L.; Fritsch-Decker, S.; Kielmeier, U.; Wagbo, A.M.; Voss, B.; Schmidt, A.; Hessman, S.D.; Duschl, A.; Oostingh, G.J.; et al. The protein corona suppresses the cytotoxic and pro-inflammatory response in lung epithelial cells and macrophages upon exposure to nanosilica. Arch. Toxicol. 2019, 93, 871–885. [Google Scholar] [CrossRef] [PubMed]
  8. Wittig, A.; Gehrke, H.; Del Favero, G.; Fritz, E.M.; Al-Rawi, M.; Diabate, S.; Weiss, C.; Sami, H.; Ogris, M.; Marko, D. Amorphous Silica Particles Relevant in Food Industry Influence Cellular Growth and Associated Signaling Pathways in Human Gastric Carcinoma Cells. Nanomaterials 2017, 7, 18. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  9. Mulhopt, S.; Diabate, S.; Dilger, M.; Adelhelm, C.; Anderlohr, C.; Bergfeldt, T.; Gomez de la Torre, J.; Jiang, Y.; Valsami-Jones, E.; Langevin, D.; et al. Characterization of Nanoparticle Batch-To-Batch Variability. Nanomaterials 2018, 8, 311. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  10. Diabate, S.; Armand, L.; Murugadoss, S.; Dilger, M.; Fritsch-Decker, S.; Schlager, C.; Beal, D.; Arnal, M.E.; Biola-Clier, M.; Ambrose, S.; et al. Air-Liquid Interface Exposure of Lung Epithelial Cells to Low Doses of Nanoparticles to Assess Pulmonary Adverse Effects. Nanomaterials 2020, 11, 65. [Google Scholar] [CrossRef] [PubMed]
  11. Nelissen, I.; Haase, A.; Anguissola, S.; Rocks, L.; Jacobs, A.; Willems, H.; Riebeling, C.; Luch, A.; Piret, J.P.; Toussaint, O.; et al. Improving Quality in Nanoparticle-Induced Cytotoxicity Testing by a Tiered Inter-Laboratory Comparison Study. Nanomaterials 2020, 10, 1430. [Google Scholar] [CrossRef] [PubMed]
  12. Hund-Rinke, K.; Sinram, T.; Schlich, K.; Nickel, C.; Dickehut, H.P.; Schmidt, M.; Kuhnel, D. Attachment Efficiency of Nanomaterials to Algae as an Important Criterion for Ecotoxicity and Grouping. Nanomaterials 2020, 10, 1021. [Google Scholar] [CrossRef] [PubMed]
  13. Von Mikecz, A.; Schikowski, T. Effects of Airborne Nanoparticles on the Nervous System: Amyloid Protein Aggregation, Neurodegeneration and Neurodegenerative Diseases. Nanomaterials 2020, 10, 1349. [Google Scholar] [CrossRef] [PubMed]
  14. Siemer, S.; Wunsch, D.; Khamis, A.; Lu, Q.; Scherberich, A.; Filippi, M.; Krafft, M.P.; Hagemann, J.; Weiss, C.; Ding, G.B.; et al. Nano Meets Micro-Translational Nanotechnology in Medicine: Nano-Based Applications for Early Tumor Detection and Therapy. Nanomaterials 2020, 10, 383. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Weiss, C.; Diabaté, S. Toxicology and Biocompatibility of Nanomaterials. Nanomaterials 2021, 11, 3110. https://doi.org/10.3390/nano11113110

AMA Style

Weiss C, Diabaté S. Toxicology and Biocompatibility of Nanomaterials. Nanomaterials. 2021; 11(11):3110. https://doi.org/10.3390/nano11113110

Chicago/Turabian Style

Weiss, Carsten, and Silvia Diabaté. 2021. "Toxicology and Biocompatibility of Nanomaterials" Nanomaterials 11, no. 11: 3110. https://doi.org/10.3390/nano11113110

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop